Gilead Sciences, Inc. (GILD) Tops Q3 EPS by 1c, Sales Fall Inline
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $151.00 -0.15%
Revenue Growth %: -0.3%
Financial Fact:
Income from operations: 4.4B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -0.3%
Financial Fact:
Income from operations: 4.4B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Gilead Sciences, Inc. (NASDAQ: GILD) reported Q3 EPS of $1.02, $0.01 better than the analyst estimate of $1.01. Revenue for the quarter came in at $2.12 billion versus the consensus estimate of $2.11 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance
- Brady Corp. (BRC) Tops Q4 EPS by 1c ; Offers Guidance
- Campbell Soup (CPB) Reports In-Line Q4 EPS, Misses on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
